quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:52:30·346d
ANALYSTRating
Affimed N.V. logo

Affimed Therapeutics downgraded by Leerink Partners

AFMD· Affimed N.V.
Health Care
Original source

Companies

  • AFMD
    Affimed N.V.
    Health Care

Recent analyst ratings

  • May 14UpdateH.C. Wainwright-
  • May 13UpdateLeerink Partners-
  • Dec 12UpdateH.C. Wainwright$6.00
  • Oct 10UpdateStifel$2.00
  • Aug 18UpdateWells Fargo-
  • Mar 31UpdatePiper Sandler$7.00

Related

  • SEC338d
    Amendment: SEC Form SCHEDULE 13G/A filed by Affimed N.V.
  • ANALYST345d
    Affimed Therapeutics downgraded by H.C. Wainwright
  • SEC345d
    SEC Form 6-K filed by Affimed N.V.
  • PR345d
    Affimed Announces Receipt of Nasdaq Delisting Notice
  • SEC346d
    SEC Form 6-K filed by Affimed N.V.
  • PR346d
    Affimed Announces Filing for the Opening of Insolvency Proceedings
  • SEC357d
    SEC Form NT 20-F filed by Affimed N.V.
  • PR360d
    Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022